Dorsey Wright & Associates’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Dorsey Wright & Associates’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,041	Closed	-$261K	–	130
2015 Q3	$261K	Buy	6,041 +1,101	+22%	+$46.5K	0.14%	83
2015 Q2	$216K	Buy	+4,940	New	+$208K	0.1%	101
2014 Q3	–	Sell	-3,914	Closed	-$126K	–	168
2014 Q2	$126K	Buy	3,914 +55	+1%	+$1.88K	0.01%	148
2014 Q1	$137K	Sell	3,859 -66	-2%	-$2.42K	0.02%	131
2013 Q4	$136K	Buy	+3,925	New	+$124K	0.02%	114

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Dorsey Wright & Associates's WX Position: Q4 2015 in Review

Dorsey Wright & Associates sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 6,041 shares — an estimated $261K sold.

Dorsey Wright & Associates first reported a position in WX in Q4 2013 and held it in 5 quarters. The position peaked at $261K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Dorsey Wright & Associates reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Dorsey Wright & Associates sold 6,041 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $261K.
Dorsey Wright & Associates first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 5 quarters.
Dorsey Wright & Associates's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $261K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Dorsey Wright & Associates's 13F filing for Q4 2015, filed 29 Jan 2016.